2000-01-27T00:00:00
The National Institute for Clinical Excellences decision to reject the new flu treatment Relenza is a move the drug companies are not taking lying down.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud